Moderna, Inc. vs PhoenixBio Co., Ltd.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $12 M for PhoenixBio Co., Ltd., 7511 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Mar 8, 2026 for PhoenixBio Co., Ltd.). PhoenixBio Co., Ltd.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Moderna, Inc. MRNA · #275 in the world | PhoenixBio Co., Ltd. 6190.T |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇯🇵 Japan |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | — |
| Size | ||
| Market cap | $90.1 B | $12 M* |
| Revenue | $1.9 B | — |
| Net income | $-2.8 B | — |
| Employees | 4,700 | — |
| Valuation | ||
| Price to sales | 35.7× | — |
| Price to book | 10.4× | — |
| Free cash flow yield | -2.3% | — |
| Profitability | ||
| Gross margin | 55.4% | — |
| Operating margin | -158.1% | — |
| Net margin | -145.2% | — |
| Return on equity | -28.9% | — |
| Growth | ||
| Revenue growth | -39.9% | — |
| Revenue growth, 3 years a year | -53.4% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -106.2% | — |
| Shareholder returns | ||
| Shareholder yield | 0.0% | — |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Mar 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Moderna, Inc. or PhoenixBio Co., Ltd.?
Moderna, Inc. is the larger company by market value: $90.1 B against $12 M for PhoenixBio Co., Ltd., 7511 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Mar 8, 2026 for PhoenixBio Co., Ltd.). PhoenixBio Co., Ltd.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
More about Moderna, Inc.
More about PhoenixBio Co., Ltd.
Sources#
Every figure on this page comes from these, with the date shown next to it.